Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

ARS Pharmaceuticals (NASDAQ:SPRY) partners with ALK to co-promote neffy, an epinephrine nasal spray, to 9,000 pediatricians.

The FDA has approved Atzumi (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

SACRAMENTO – Governor Newsom announced that individual twin-packs of CalRx®-branded over-the-counter (OTC) naloxone HCL 4 mg nasal spray are now available to all Californians at a low price of $24 per ...

DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...

A Utah manufacturer says the truth prevailed. But a former federal regulator believes the dismissal of the case against Xlear ...

The FDA has expanded the approval of Valtoco (diazepam nasal spray) to include treatment of seizure clusters in patients aged 2 to 5 years.

Chennai: Marumalarchi Dravida Munnetra Kazhagam (MDMK) principal secretary Durai Vaiko has withdrawn his resignation after the party’s administrative committee meeting, where his father, general ...

Property News: For $30million you can live next door to Amazon billionaire Jeff Bezos. © 2025 Nine Entertainment Co.

Claritin, or Allegra should help, Rubin says. Astepro is a nasal spray with antihistamine, which Rubin usually recommends pairing with a steroid spray. Steroid nasal sprays. If you've got congestion ...